Serelaxin Inhibits Lipopolysaccharide-induced Inflammatory Response in Cardiac Fibroblasts by Activating Peroxisome Proliferator-activated Receptor-γ and Suppressing the Nuclear Factor-Kappa B Signaling PathwayXueping Wu, Zhifang Yang|Journal of Cardiovascular Pharmacology|2023Cited by 5